KALV Kalvista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.

$17.22  -0.27 (-1.54%)
As of 10/15/2021 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/09/2015
Outstanding shares:  24,437,866
Average volume:  235,136
Market cap:   $427,418,276
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    483497103
ISIN:        US4834971032
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.63
PS ratio:   0.00
Return on equity:   -21.09%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy